The Disability Rights Critique of Technologies that Eliminate Human Genetic Variation
By Rosemarie Garland-Thomson,
ELSIhub
| 04. 12. 2023
Photo by Kimberly Farmer on Unsplash
Introduction
The development and use of an expanding range of medical technologies that yield genetic information about embryos and fetuses has raised ethical questions about whether and how this increasingly routine set of practices discriminates against people with disabilities. A conversation in the form of academic articles and public media offers explications and critiques about the social and moral harms human gene editing and prenatal genetic testing and the selective reproduction practices it prompts bring to humanity. These purported harms range from increased social inequity—at the very least—to structural and individual violence—at the very most.
This collection suggests that conversations about these technologies have changed over time and also reflects the varied communities engaged in those conversations over time and across social locations. The collection thus focuses on the health humanities in the broadest sense. This means that the data, evidence, and knowledge it gathers come from the lives of individuals, families, and human communities who live with disabilities and illnesses, not from medical-scientific or clinical data. The stories in the final section of...
Related Articles
Since the “CRISPR babies” scandal in 2018, no additional genetically modified babies are known to have been born. Now several techno-enthusiastic billionaires are setting up privately funded companies to genetically edit human embryos, with the explicit intention of creating genetically modified children.
Heritable genome editing remains prohibited by policies in the overwhelming majority of countries that have any relevant policy, and by a binding European treaty. Support for keeping it legally off limits is widespread, including among scientists...
By Ed Cara, Gizmodo | 06.22.2025
In late May, several scientific organizations, including the International Society for Cell and Gene Therapy (ISCT), banded together to call for a 10-year moratorium on using CRISPR and related technologies to pursue human heritable germline editing. The declaration also outlined...
By Isabel van Brugen, Newsweek | 06.05.2025
A U.S.-based biotech company has unveiled a new in vitro fertilization (IVF) option that allows parents to select embryos based on genetic markers tied to health and longevity.
DNA testing and analysis company Nucleus Genomics has announced the world's first...
By Jonathan D. Grinstein, PhD, Inside Precision Medicine | 06.03.2025
On Tuesday, 307 days after he was first admitted to Children’s Hospital of Philadelphia (CHOP), KJ Muldoon went home after being successfully treated with the first personalized CRISPR gene editing therapy. KJ, who was born with a serious and...